HARVARD BIOSCIENCE, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
HARVARD BIOSCIENCE, INC. (HBIO) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $143.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2020-03-16
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-06-30 was -$493.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-03-31 was -$192.00K, a 115.34% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2018-12-31 was -$2.26M, a 248.39% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2018-09-30 was $521.00K, a 55.88% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2019 was $143.00K.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2018 was -$3.27M, a 158.12% decline from fiscal 2017.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2017 was $5.62M.
- HARVARD BIOSCIENCE, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2016 was -$5.07M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2019-12-31 | $143.00K 10-K · filed 2020-03-16 | |||
| 2019-06-30 | -$493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$685.00K 10-Q · filed 2019-08-08 | -$2.94M derived: sum of 3 quarters · filed 2020-03-16 | -$2.42M derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | -$192.00K 10-Q · filed 2019-05-08 | -$2.45M derived: sum of 2 quarters · filed 2020-03-16 | -$1.93M derived: sum of 3 quarters · filed 2020-03-16 | -$4.71M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$1.74M derived: sum of 2 quarters · filed 2020-03-16 | -$4.52M derived: sum of 3 quarters · filed 2020-03-16 | -$3.27M 10-K · filed 2020-03-16 |
| 2018-09-30 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$2.26M derived: sum of 2 quarters · filed 2018-11-01 | -$1.01M 10-Q · filed 2018-11-01 | $511.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-06-30 | -$2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$1.53M 10-Q · filed 2018-08-02 | -$10.00K derived: sum of 3 quarters · filed 2019-03-18 | $1.17M derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-03-31 | $1.25M 10-Q · filed 2018-05-10 | $2.77M derived: sum of 2 quarters · filed 2019-03-18 | $3.95M derived: sum of 3 quarters · filed 2019-03-18 | $5.93M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.70M derived: sum of 2 quarters · filed 2019-03-18 | $4.67M derived: sum of 3 quarters · filed 2019-03-18 | $5.62M 10-K · filed 2019-03-18 |
| 2017-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $3.15M derived: sum of 2 quarters · filed 2017-11-02 | $4.10M 10-Q · filed 2017-11-02 | $462.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.92M 10-Q · filed 2017-08-03 | -$719.00K derived: sum of 3 quarters · filed 2018-03-16 | -$893.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | $946.00K 10-Q · filed 2017-05-08 | -$2.69M derived: sum of 2 quarters · filed 2018-03-16 | -$2.87M derived: sum of 3 quarters · filed 2018-03-16 | |
| 2016-12-31 | -$3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$3.81M derived: sum of 2 quarters · filed 2018-03-16 | -$5.07M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.43M 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | -$1.25M 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | -$619.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$1.18M derived: sum of 2 quarters · filed 2017-03-17 | $564.00K derived: sum of 3 quarters · filed 2017-03-17 | -$3.99M 10-K · filed 2017-03-17 |
| 2015-09-30 | -$565.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.18M derived: sum of 2 quarters · filed 2015-11-05 | -$3.37M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$2.81M 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | -$4.56M 10-Q · filed 2015-05-07 | |||
| 2014-12-31 | -$5.93M 10-K · filed 2016-04-29 | |||
| 2014-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $20.00K 10-Q · filed 2014-08-07 | ||
| 2014-03-31 | $191.00K 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | $1.91M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |